The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...
Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...
"The stem cell of the fetal pancreas is present longer than scientists have seen in earlier studies with mice," Andersson Rolf says. Interestingly, the organoids grown from one of these stem cells ...
Hemagglutination would be positive for maternal cells that have been bound with ... Kleihauer-Betke acid elution tes 1 Fetal hemoglobin resists release (or elution) from its RBC under acid ...
Useful in establishing the differential diagnosis of anemia, calculated by automated blood profiling machine from RBC count, hematocrit and hemoglobin Red Cell Distribution Width (RDW) Expresses ...
The FDA granted accelerated approval to the bispecific antibody zenocutuzumab (Bizengri) for NRG1 gene fusion-positive ...
A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining ...
On December 4, 2024, the Food and Drug Administration granted accelerated approval to Merus (MRUS)’ zenocutuzumab-zbco for adults with the ...
Zenocutuzumab, a bispecific antibody, is indicated for non-small-cell lung cancer and pancreatic adenocarcinoma with NRG1 ...
Merus (MRUS) announced that the FDA approved BIZENGRI(R) (zenocutuzumab-zbco), the first and only treatment indicated for ...
The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.